期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 128, 期 7, 页码 2724-2731出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI97951
关键词
-
资金
- NIH [T90DE021985, T32HL066988, T32ES007026, R01HL120908, R01HD069313, R21AI103690, P30ES001247]
- Mary Parkes Asthma Center
- C. Jane Davis and C. Robert Davis Professorship
- Wright Family Professorship
Chronic inflammation is an underlying feature of many diseases, including chronic obstructive pulmonary disease, rheumatoid arthritis, asthma, and multiple sclerosis. There is an increasing appreciation of the dysregulation of adaptive immunity in chronic inflammatory and allergic diseases. The discovery of specialized pro-resolving lipid mediators (SPMs) that actively promote the resolution of inflammation has opened new avenues for the treatment of chronic inflammatory diseases. Much work has been done focusing on the impact of SPMs on innate immune cells. However, much less is known about the influence of SPMs on the development of antigen-specific adaptive immune responses. This Review highlights the important breakthroughs concerning the effects of SPMs on the key cell types involved in the development of adaptive immunity, namely dendritic cells, T cells, and B cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据